Colossal Biosciences, the world's first de-extinction company, has today announced $200M in a Series C financing by TWG ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 and 20, during times of rapid bone growth. Although rare, it has a ...

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

DNA sequencing was revolutionized after scientists discovered a new bacterium in the hot springs of Yellowstone National Park ...

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

The new insights on osteosarcome could, with time, lead to better treatment options and outcomes for patients through more ...

Cerebras Systems, in collaboration with Mayo Clinic, announced significant progress in developing artificial intelligence ...

Cerebras Systems (a client of Cambrian-AI Research) announced a new foundation model co-developed with partner The Mayo ...

Osteosarcoma is a type of aggressive bone cancer that most commonly affects children and young adults between the ages of 10 ...

A new study reveals a mutation mechanism in osteosarcoma, promising advances in treatment and prognosis for this challenging ...

Commenced shipment of the Vega™ benchtop system ahead of schedule, bringing HiFi sequencing to more customers Launched SPRQ chemistry, enabling the sub-$500 HiFi genome on the Revio® system MENLO PARK ...